Article
Precision medicine in diabetes: A non-invasive prenatal diagnostic test for the determination of fetal glucokinase mutations.
Journal of diabetes investigation - 1 Feb 2022
Nouspikel Thierry, Blouin Jean-Louis, Puder Jardena J, Köhler Ballan Bettina, Schwitzgebel Valerie M
Abstract excerpt
Hyperglycemia caused by mutations in the glucokinase gene, GCK, is the most common form of monogenic diabetes. Prenatal diagnosis is important, as it impacts on treatment. This study reports a monogenic non-invasive prenatal diagnostic (NIPD-M) test on cell-free DNA in maternal plasma using the relative haplotype dosage. In three pregnancies of two families with known maternal GCK mutations, the fetal genotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
